Deals
CD&R Nears €15 billion Deal for Sanofi Consumer Health Unit
- Private equity firm sees off rival bidder PAI Partners
- Sanofi is likely to retain a minority stake in Opella unit
Photographer: Nathan Laine/Bloomberg
This article is for subscribers only.
Clayton Dubilier & Rice is nearing a deal to acquire Sanofi’s consumer health unit for about €15 billion ($16.4 billion), in what would be one of the largest European transactions this year, people familiar with the matter said.
The private equity firm has seen off interest from rival PAI Partners for the Opella unit, according to the people, who asked not to be identified discussing confidential information. A deal could be announced in the coming days, they said.